(Bloomberg) -- One of this year’s hottest themes in the stock market has been the crowds of traders chasing the recipients of all the planned spending on new artificial-intelligence data centers. Most Read from BloombergNvidia’s $750 Billion in Deals Reignite Circular AI FearsChip Rout Deepens on Circular Funding, China Competition FearsCitadel Securities Sees Warsh Delivering Surprise Fed HikeDeepSeek Suspends Fundraising After Viral US-China PostsS&P 500 Wobbles as AI Angst Offsets Oil Decline
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Wall Street's Monday morning desk just sent five coordinated buy signals across cybersecurity, quantum computing, EVs, and a legacy audio brand sitting on a spectrum asset the market wildly undervalued. One analyst literally quintupled a price target overnight.
Wells Fargo (WFC) has launched a fresh batch of fixed income offerings, issuing new senior unsecured notes with fixed coupons across 2030, 2031, 2033, 2038, 2041 and 2046 maturities, giving investors more ways to access the bank’s credit. See our latest analysis for Wells Fargo. The latest bond issuance comes after a period where Wells Fargo’s share price has delivered a 5.90% 90 day share price return and a 6.18% 1 year total shareholder return. The year to date share price return is down...
C's record Q2 results, transformation plan and shareholder returns fuel optimism, but does its valuation still leave room for more upside? Let us find out.
Wells Fargo began coverage on five biotech stocks on Monday, with only Compass Pathways receiving an ‘Equal-Weight’ rating while the rest received ‘Overweight’ ratings.
In his Tuesday appearance on Squawk on the Street, Jim Cramer continued to assert that Wells Fargo & Company (NYSE:WFC)’s multiple was too low. Throughout the course of this year, the CNBC TV host has maintained that banking stocks are trading at low multiples. As for Wells Fargo & Company (NYSE:WFC), he has asserted that […]
(Bloomberg) -- Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, surged 67% on Friday after raising $128.7 million in an upsized initial public offering.Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump Rebuilds Tariffs With New Levies on 60 EconomiesSpaceX Turns Away Falcon Customers in Majo
BAC's AI-powered virtual assistant, Erica, is driving higher digital engagement, supporting sales growth.
Wall Street strategists are calling July's chip carnage a gift, and the reasoning comes down to a capital spending figure so large it dwarfs anything the semiconductor industry has absorbed before. The question is whether the underlying earnings can actually justify it.
According to TheFly, Wells Fargo lowered the price target for Arm to $350 from $410 while maintaining an ‘Overweight’ rating on the stock.
Based on the average brokerage recommendation (ABR), Wells Fargo (WFC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Zacks.com users have recently been watching Wells Fargo (WFC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Jim Cramer is sounding the alarm for investors still riding the AI wave, and his warning carries a specific body count. Here is where he says the smart money is quietly moving before the damage hits.
Wells Fargo (NYSE:WFC) has appointed Tom Nicholls as head of its Sports Investment Banking operations. Nicholls joins from PJT Partners Inc., bringing experience in sports focused deals to the bank. The move signals an internal focus on sports related finance and advisory work within Wells Fargo's investment banking arm. Wells Fargo, trading at $87.74 per share, is adding a new specialist leader at a time when its stock is up 2.9% over the past week and 6.7% over the past month. Over longer...
Wells Fargo announced plans to raise its dividend by 11% to $0.50 per share from $0.45 after the Federal Reserve’s stress test showed its CET1 ratio remaining well above requirements.
EPS surged 25% as revenue growth and efficiency gains accelerated across all segments.
(Bloomberg) -- Frank Bisignano, the head of the Internal Revenue Service and Social Security Administration, denied a report in the Wall Street Journal that he spied on colleagues while at JPMorgan Chase.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Camp
(Bloomberg) -- Strong economic momentum is a double-edged sword for US equity traders. Solid growth is an earnings tailwind. But let it run too hot, and it turns from blessing to curse.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Campaign After Troops K
Jim Cramer took a bullish stance on Alibaba despite its brutal year-to-date slide, pairing the call with two steady compounders he thinks belong in every long-term portfolio. Here is what he told one caller sitting on a sizable BABA position.
Wells Fargo just slashed its price targets on two major cybersecurity stocks while keeping cautious ratings intact, and that contradiction tells investors something important about where this red-hot sector actually stands heading into 2026.
Investing.com -- Wells Fargo downgraded HubSpot to Equal Weight from Overweight and slashed its price target to $225 from $300, arguing that the software company's broad artificial intelligence transition is creating near-term uncertainty despite strengthening its long-term competitive position.
“Too big to fail” is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their ability to find new sources of growth.
Goldman Sachs just added three stocks to its closely watched Conviction List, and at least two of them carry the kind of upside potential that makes investors stop scrolling. One name in the beauty space and one in clean energy could be sitting on gains most people have not yet noticed.
Marc Chaikin of Chaikin Analytics breaks down bank earnings, mega-cap tech divergence, oversold chip stocks, SpaceX's post-IPO slide and mid-cap names like Avnet this earnings season.
Magnolia Oil & Gas (MGY) said Monday that it has signed a definitive agreement to acquire WildFire E